EDIT:NASDAQ
Editas Medicine Inc
$2.63
arrow_downward
-4.01%(-0.11) 1D
$2.65
arrow_upward
+0.76% (+0.020)bedtimeAfter hours
Closed: Sep 15, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.70
High
$2.71
Low
$2.59
Mkt. cap
403.92M
Avg. vol.
2.41M
Volume
1.68M
52-wk high
$4.54
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
Open
$2.70
High
$2.71
Low
$2.59
Mkt. cap
403.92M
Avg. vol.
2.41M
Volume
1.68M
52-wk high
$4.54
52-wk low
$1.66
EPS
-$0.74
Beta
2.09
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Benzinga
·
19 hours ago
Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc